Limits On 'Orphan Drug' Tax Credit Face Pushback In Senate

By Alan K. Ota · March 3, 2022, 3:40 PM EST

A House-passed plan to raise revenue for Democratic priorities by limiting tax breaks for so-called orphan drugs used to treat rare diseases faces Senate hurdles as allies of the pharmaceutical industry...

To view the full article, register now.